Cargando…
Immunosenescence in neurocritical care
BACKGROUND: Several advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186132/ https://www.ncbi.nlm.nih.gov/pubmed/30349725 http://dx.doi.org/10.1186/s40560-018-0333-5 |
_version_ | 1783362818239627264 |
---|---|
author | Inoue, Shigeaki Saito, Masafumi Kotani, Joji |
author_facet | Inoue, Shigeaki Saito, Masafumi Kotani, Joji |
author_sort | Inoue, Shigeaki |
collection | PubMed |
description | BACKGROUND: Several advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including sepsis is increasing, and patients with such disorders often find themselves in the ICU. MAIN BODY: Age-related diseases are closely related to age-induced immune dysfunction, by which reductions in the efficiency and specificity of the immune system are collectively termed “immunosenescence.” The most noticeable is a decline in the antigen-specific acquired immune response. The exhaustion of T cells in elderly sepsis is related to an increase in nosocomial infections after septicemia, and even death over subacute periods. Another characteristic is that senescent cells that accumulate in body tissues over time cause chronic inflammation through the secretion of proinflammatory cytokines, termed senescence-associated secretory phenotype. Chronic inflammation associated with aging has been called “inflammaging,” and similar age-related diseases are becoming an urgent social problem. CONCLUSION: In neuro ICUs, several neuro-related diseases including stroke and sepsis-associated encephalopathy are related to immunosenescence and neuroinflammation in the elderly. Several advanced countries with superaged societies face the new challenge of improving the long-term prognosis of neurocritical patients. |
format | Online Article Text |
id | pubmed-6186132 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61861322018-10-22 Immunosenescence in neurocritical care Inoue, Shigeaki Saito, Masafumi Kotani, Joji J Intensive Care Review BACKGROUND: Several advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including sepsis is increasing, and patients with such disorders often find themselves in the ICU. MAIN BODY: Age-related diseases are closely related to age-induced immune dysfunction, by which reductions in the efficiency and specificity of the immune system are collectively termed “immunosenescence.” The most noticeable is a decline in the antigen-specific acquired immune response. The exhaustion of T cells in elderly sepsis is related to an increase in nosocomial infections after septicemia, and even death over subacute periods. Another characteristic is that senescent cells that accumulate in body tissues over time cause chronic inflammation through the secretion of proinflammatory cytokines, termed senescence-associated secretory phenotype. Chronic inflammation associated with aging has been called “inflammaging,” and similar age-related diseases are becoming an urgent social problem. CONCLUSION: In neuro ICUs, several neuro-related diseases including stroke and sepsis-associated encephalopathy are related to immunosenescence and neuroinflammation in the elderly. Several advanced countries with superaged societies face the new challenge of improving the long-term prognosis of neurocritical patients. BioMed Central 2018-10-12 /pmc/articles/PMC6186132/ /pubmed/30349725 http://dx.doi.org/10.1186/s40560-018-0333-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Inoue, Shigeaki Saito, Masafumi Kotani, Joji Immunosenescence in neurocritical care |
title | Immunosenescence in neurocritical care |
title_full | Immunosenescence in neurocritical care |
title_fullStr | Immunosenescence in neurocritical care |
title_full_unstemmed | Immunosenescence in neurocritical care |
title_short | Immunosenescence in neurocritical care |
title_sort | immunosenescence in neurocritical care |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186132/ https://www.ncbi.nlm.nih.gov/pubmed/30349725 http://dx.doi.org/10.1186/s40560-018-0333-5 |
work_keys_str_mv | AT inoueshigeaki immunosenescenceinneurocriticalcare AT saitomasafumi immunosenescenceinneurocriticalcare AT kotanijoji immunosenescenceinneurocriticalcare |